骨髓灰质炎的患病率在炎症性肠道疾病中增加
Antônio Miguel Furtado Leitão1, Florian P Thomas2, Marcellus Henrique Loiola Ponte de Souza3
1Universidade Federal do Ceará, Faculdade de Medicina, Departamento de Morfologia, Fortaleza CE, Brazil.
Arquivos de neuro-psiquiatria
|May 13, 2025
概括
骨髓灰质炎 (MG) 在炎症性肠病 (IBD) 患者中更为常见. 这项研究发现IBD患者的MG患病率较高,包括罕见病例和小纤维神经病变.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 副发病性自身免疫性疾病存在于~0.2%的人口中.
- 高达15%的肌痛性骨髓灰质炎 (MG) 患者会发展出第二种自身免疫性疾病.
- 调查MG和炎症性肠病 (IBD) 之间的关联对于了解疾病重叠至关重要.
研究的目的:
- 评估骨髓灰质炎 (MG) 和炎症性肠病 (IBD) 之间的关联.
- 为了确定巴西IBD患者队列中MG的患病率.
- 审查有关MG和IBD同时发生的现有文献.
主要方法:
- 在巴西,对606名IBD患者进行了横截面研究.
- 进行了全面的文献审查,以收集相关数据.
- 通过将IBD患者的MG与一般人群进行比较,计算了患病率.
主要成果:
- 在IBD队列中观察到0.66%的MG患病率 (4/606名患者).
- 在IBD患者中,MG的患病率明显高 (8.56,p < 0.0001).
- 该研究在IBD患者中确定了抗肌肉特异性激酶阳性MG,这是一个新发现,并且经常与小纤维神经病变重叠.
结论:
- 在患有炎症性肠病 (IBD) 的患者中,肌痛性肠病 (MG) 的患病率显著更高.
- 在IBD患者的MG诊断可以通过免疫疗法掩盖,需要仔细评估.
- 这些发现强调了在IBD患者中识别MG的重要性,并表明了与其他自身免疫疾病和神经病变的潜在联系.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
561
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
561
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
Inflammatory Bowel Disease II: Crohn's Disease
132
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
132
Inflammatory Bowel Disease I: Ulcerative Colitis
98
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
98
Chronic Bowel Disorders: Introduction
336
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
336
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
253
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
253


